Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 305.35
-7.85 (-2.51%)
May 25, 2026, 10:00 AM IST
Suraksha Diagnostic Revenue
In the fiscal year ending March 31, 2026, Suraksha Diagnostic had annual revenue of 3.14B INR with 24.39% growth. Suraksha Diagnostic had revenue of 821.97M in the quarter ending March 31, 2026, with 32.44% growth.
Revenue
3.14B
Revenue Growth
+24.39%
P/S Ratio
5.20
Revenue / Employee
2.41M
Employees
1,300
Market Cap
16.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.14B | 614.86M | 24.39% |
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 604.34B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 103.14B |
| Indoco Remedies | 18.45B |
| Shalby | 11.19B |
| Windlas Biotech | 9.22B |
| Krsnaa Diagnostics | 7.66B |